|
 |
NilandronThis page contains recent news articles, when available, and an overview of Nilandron but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Nilandron (when available) Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Nilutamide blocks the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration. Used as an add-on therapy following surgical or chemical castration due to prostate cancer Mechanism Of Action: Nilutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. News Articles on Nilutamide Recurrent PCa responds to hormone-vaccine combination. - Aug 15, 2005 12 elected to add the antiandrogenic nihitamide (Nilandron) to their regimen, more than doubling their median time to treatment failure from 9.9 months ... Free with registration - Urology Times - AccessMyLibrary.com Fracture Risk Rises With Prostate Cancer Drugs - Jan 12, 2005 ...—Casodex, Eulixin and Nilandron. About 10 percent of testosterone is produced by the ... Casodex (search), Eulixin (search), and Nilandron (search) are ... FOXNews Press Release: Super Prostate Product - More Beta-sitosterol, all... - Feb 28, 2008 Article: Nilandron(TM) for Prostate Cancer Now Available in ... PR Newswire; November 6, 1996 ; 700+ words ... ... announced that Nilandron(TM) (nilutamide) ... Pay-Per-View - PR Newswire - HighBeam Research Prostate Cancer Vaccine Before Hormones May Boost Survival - Jul 10, 2008 ...at any point tended to be extended by almost two years compared with those given the antiandrogen drug nilutamide (Nilandron) alone (median 5.1 vs. ... MedPage Today Prostate Cancer Vaccine Boosts Hormone Therapy - Jul 25, 2005 The patients were randomly assigned to either a recombinant prostate cancer vaccine or Nilandron (nilutamide), a second-line hormone therapy, for six months ... MedPage Today Hormone therapy for prostate cancer (androgen deprivation therapy, or... - Jun 27, 2008 The "pure" or nonsteroidal antiandrogens include bicalutamide (Casodex), flutamide (Eulexin), and nilutamide (Nilandron). Orchiectomy. ... MSN Health & Fitness Prostate cancer: New studies of combination therapy. - Jan 1, 2005 The major preparations include bicalutamide (Casodex), flutamide (Eulexin), and nilutamide (Nilandron). All are taken orally, and all are expensive. ... Free with registration - Harvard Men's Health Watch - AccessMyLibrary.com Benefits of combined blockade may outweigh risks.(Data show extended ... - Apr 1, 2006 The results showed that maximum androgen blockade with nilutamide (Nilandron) or flutamide (Eulexin) slightly improves 5year survival over androgen ... $4.95 - Urology Times - ECNext Article: L'Oreal fights ovarian cancer.(What's News)(Hearst Magazines)... - Sep 3, 2007 ...s treatment for pancreatic cancer; Hycamtin, an ovarian cancer drug developed by SmithKline Beecham PLC; Nilandron from Hoechst ... prostate cancer; ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: Husband and wife convicted of stealing life insurance ... - Jul 28, 2006 M2 Presswire; July 8, 1998 ; 700+ words ... ... company/products/nilandron.html "Prostate cancer information will be readily accessible 24 hours a day," ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: "Testicle Pizza", "Battered Testicles" Among 31... - Oct 2, 2008 ...production) or ... receiving Nilandron immediately after surgical removal of the testicles experienced statistically significant improvement in bone ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Menocease.com- are you looking for natural alternative... - Aug 3, 2005 The most common side effects that occurred more often with Nilandron than placebo include hot flushes (28.4%), impaired adaptation to dark (12.9%), ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Cytogen Announces Positive Phase 1 Clinical Trial … - Nov 7, 2006 Article: Nilandron(TM) for Prostate Cancer Now Available in ... PR Newswire; November 6, 1996 ; 700+ words ... ... The risk of developing prostate cancer ... Pay-Per-View - PR Newswire - HighBeam Research Brand Names/Synonyms: Nilandron is also known by the following brand names and/or synonymsAnandron; CHEMBANK1765; Nilandron; Nilandrone; Nilutamida [Spanish]; Nilutamide; Nilutamide [Usan:Ban:Inn]; Nilutamidum [Latin] Drug Category: Nilandron is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BB02 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-imidazolidine-2,4-dione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |